Division of Nephrology and Hypertension

Shown here are members of the team working to evaluate new drug candidates for the treatment of kidney diseases.
October 6, 2022

Kidney diseases research collaboration renewed

Vanderbilt University Medical Center and Bayer have agreed to continue a strategic research alliance to evaluate new drug candidates for the treatment of kidney diseases.

By Nancy Humphrey
October 4, 2022

Vanderbilt’s Terker wins NIH Director’s Early Independence Award

Andrew Terker, MD, PhD, a physician-scientist at Vanderbilt University Medical Center who is committed to advancing the understanding and treatment of kidney disease, has received a 2022 National Institutes of Health Director’s Early Independence Award.

By Bill Snyder
August 25, 2022

Inflammatory driver of obesity

Blocking the EGF receptor signaling pathway in immune system macrophages represents a new target for improving insulin resistance in people with obesity.

By Sarah E. Glass
From left, Raymond C. Harris, MD, Shirong Cao, MD, PhD, Ming-Zhi Zhang, MD, MSc, and colleagues are studying the role of inflammation in obesity.
May 12, 2022

Study sheds light on the dark side of obesity

Vanderbilt research that promotes the anti-inflammatory pathway in macrophages could also reduce some of the bad side effects of obesity.

By Bill Snyder
May 12, 2022

Fissell receives Medal of Excellence from the American Association of Kidney Patients

Vanderbilt’s William Fissell, MD, recently received the 2022 Medal of Excellence Award in the physician category from the American Association of Kidney Patients.

By Emily Stembridge
April 13, 2022

Arroyo, Terker receive new awards from ASCI

Juan Pablo Arroyo, MD, PhD, instructor of Medicine in the Division of Nephrology and Hypertension, and Andrew Terker, MD, PhD, research fellow in Nephrology, each received an inaugural 2022 Emerging Generation Award from the American Society for Clinical Investigation.

By Emily Stembridge
April 6, 2022

Schaefer named Adult Solid Organ Transplant Center medical director

Heidi Schaefer, MD, has been named medical director of the Adult Solid Organ Transplant Center at Vanderbilt University Medical Center.
By Matt Batcheldor
March 17, 2022

Study compares kidney injury risk for COVID, flu patients

A Vanderbilt study found that renin-angiotensin-aldosterone system (RAASi) inhibitor drugs, which are commonly used to regulate high blood pressure, do not disproportionately increase the risk of acute kidney injury (AKI) in patients with COVID-19 compared to patients hospitalized with influenza.
By Emily Stembridge
February 2, 2022

VUMC study raises hope for improving treatment of kidney disease

Vanderbilt research has revealed an important mechanism in the kidney by which a cell surface receptor known as DDR1 fans the flames of inflammation and fibrosis that ultimately lead to kidney failure.
By Bill Snyder
February 1, 2022

Accelerating podocyte production

A new method developed by Vanderbilt researchers to generate kidney cells from stem cells offers a faster and less expensive way to make these valuable tools for studying kidney diseases.
By Bill Snyder
January 20, 2022

Pozzi elected president of Society for Matrix Biology

Vanderbilt's Ambra Pozzi, PhD, has been elected president of the American Society for Matrix Biology (ASMB), a scientific organization that promotes research on the extracellular matrix with the aim of improving human health.
By Bill Snyder
January 13, 2022

The role of integrins in kidney “integrity”

Receptors called integrins play a critical role in maintaining the structure of the kidney, Vanderbilt researchers have discovered.
By Bill Snyder
November 11, 2021

New way to bEET insulin resistance

Signaling molecules called EETs could improve insulin resistance, a primary risk factor for Type 2 diabetes and cardiovascular disease, Vanderbilt researchers have discovered.
By Bill Snyder